Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference29 articles.
1. Identificationofmcl-1as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib andmcl-1antisense oligonucleotides;Aichberger;Blood,2005
2. Divergent effect of taxol on proliferation, apoptosis and nitricoxide production in MHH225 CD34 positive and U937 CD34 negative human leukaemia cells;Al-alami;Leuk. Res.,1998
3. A close link between Fas, p53 and Apaf-1 in chronic myeloid leukemia;Alenzi;Saudi Med. J.,2007
4. Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia;Bixby;Leukemia,2011
5. Systematic discovery of multicomponent therapeutics;Borisy;Proc. Natl. Acad. Sci. USA,2003
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia;Biochemical Journal;2023-01-31
2. Mechanisms of cancer cell death induction by paclitaxel: an updated review;Apoptosis;2022-07-18
3. New insights into binding of natural chalcones to Bcl-2, Bcl-xL and Mcl-1 anti-apoptotic proteins;Journal of Molecular Structure;2021-10
4. IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment;Blood Advances;2020-10-21
5. A Bayesian Network Meta-Analysis for Identifying the Optimal Taxane-Based Chemotherapy Regimens for Treating Gastric Cancer;Frontiers in Pharmacology;2019-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3